The Kappa Opioid Receptor -

The Kappa Opioid Receptor

Buch | Softcover
XI, 577 Seiten
2022 | 1st ed. 2022
Springer International Publishing (Verlag)
978-3-030-89076-6 (ISBN)
149,79 inkl. MwSt
This book covers the latest knowledge in structure, signaling, and biochemical pharmacology of KOR as well as preclinical research and clinical applications (including clinical phase studies and approved for human use) of KOR compounds. It is divided up into the three parts: Molecular aspects of KOR, Preclinical research on pharmacology of KOR agonists and antagonists in animals and KOR agonists and antagonists in clinical use and in past and present clinical trials.
The chapters "Biosensors monitor ligand-selective effects at kappa opioid receptors" and "The role of dynorphin and the kappa opioid receptor in schizophrenia and major depressive disorder: a translational approach" of this book are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.


From the contents. Preface.-Part I: Molecular aspects of KOR.- Part II: Preclinical research on pharmacology of KOR agonists and antagonists in animals.- Part III: KOR agonists and antagonists in clinical use and in past and present clinical trials.

Erscheinungsdatum
Reihe/Serie Handbook of Experimental Pharmacology
Zusatzinfo XI, 577 p. 100 illus., 30 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 992 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pharmazie
Schlagworte Clinical applications of kappa compounds • Kappa opioid receptor • Kappa opioid receptor agonists • Kappa opioid receptor antagonists • Kappa opioid receptor pharmacology • Kor
ISBN-10 3-030-89076-7 / 3030890767
ISBN-13 978-3-030-89076-6 / 9783030890766
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich